We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Five Prime Therapeutics announced restructuring plans that will involve eliminating 41 jobs, representing about 20 percent of its current headcount, mainly in the areas of research, pathology and manufacturing.